Prosecution Insights
Prosecution Insights
Technology area: Biotechnology & Pharmaceuticals
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready • 1 patents granted in the last 365 days
Medisca Pharmaceutique Inc. is currently active within the Biotechnology & Pharmaceuticals technology area. The company's patent portfolio shows 1 pending office action, which represents the current focus of its legal efforts at the patent office. This matter is being handled by 1 distinct examiner, indicating that the company's immediate prosecution is concentrated under a single official review process.
The prosecution activity is situated within 1 distinct art unit, which reflects a specific technical classification for the company's pending innovation. The busiest examiner for the portfolio is PROSSER, ALISSA J, who is responsible for 1 pending office action in this capacity. Because this official is the only one assigned to a matter, the entirety of the company's current pending status is tied to this single interaction.
For a patent practitioner, the presence of a single action in a unique art unit suggests a highly specialized and narrow prosecution front. With PROSSER, ALISSA J managing the workload, there is no diversification of examiner perspectives within the current data. This means that the outcome of this specific case will be the primary determinant of the company's short-term success in securing intellectual property rights within the Biotechnology & Pharmaceuticals sector.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| PROSSER, ALISSA J | 1 | 15.7% | +11.2% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18938397 | METHODS AND SYSTEMS FOR MAKING OIL-LOADED POWDERS AND USE THEREOF | PROSSER, ALISSA J | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18938397 | METHODS AND SYSTEMS FOR MAKING OIL-LOADED POWDERS AND USE THEREOF | PROSSER, ALISSA J | — |
| Art Unit | Apps |
|---|---|
| 1619 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18938397 | METHODS AND SYSTEMS FOR MAKING OIL-LOADED POWDERS AND USE THEREOF | PROSSER, ALISSA J | 1619 | §103 | Non-Final OA | — | Pending | Nov 06, 2024 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial